ResearchMoz presents this most up-to-date research on Global Osteoporosis Market, Patients, Companies & Forecast.
Osteoporosis is a silent disease until it is complicated by fractures that occur following minimal trauma or, in some cases, with no trauma. Globally Osteoporosis is expected to be more than US$ 40 Billion market by 2019. China and India together have close to 80% of osteoporosis patients worldwide. Whereas this in case of hip fracture cases both the countries China and India have more than 60% patients. But when we study Osteoporosis in market terms then United States controls the highest market share followed by China and Japan. Amgen and Eli Lilly are two dominant players in Osteoporosis drugs market.
This is the 2nd edition report on Osteoporosis by Renub Research. Report titled “Global Osteoporosis Market, Patients, Companies & Forecast” provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 124 page report with 89 Figures and 8 Tables studies the Worldwide Osteoporosis market from 6 view points:
1) Osteoporosis Patients & Forecast
2) Hip fracture Patients & Forecast
3) Osteoporosis Market & Forecast
4) Country Wise Osteoporosis level of Awareness, Guidelines & Policy
5) Country Wise Reimbursement of Medication
6) Company Wise Osteoporosis Drugs Sales & Forecast
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=423187
All the 10 Countries studied in the report are as follows
1) India
2) China
3) Japan
4) Korea
5) Brazil
6) Russia
7) United Kingdom
8) France
9) Germany
10) United States
Worldwide Osteoporosis – Company Wise Drugs Sales Analysis (2010 – 2019)
1) Merck
2) Sanofi
3) Novartis
4) Eli Lilly
5) Amgen
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephonic interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=423187
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Osteoporosis is a silent disease until it is complicated by fractures that occur following minimal trauma or, in some cases, with no trauma. Globally Osteoporosis is expected to be more than US$ 40 Billion market by 2019. China and India together have close to 80% of osteoporosis patients worldwide. Whereas this in case of hip fracture cases both the countries China and India have more than 60% patients. But when we study Osteoporosis in market terms then United States controls the highest market share followed by China and Japan. Amgen and Eli Lilly are two dominant players in Osteoporosis drugs market.
This is the 2nd edition report on Osteoporosis by Renub Research. Report titled “Global Osteoporosis Market, Patients, Companies & Forecast” provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 124 page report with 89 Figures and 8 Tables studies the Worldwide Osteoporosis market from 6 view points:
1) Osteoporosis Patients & Forecast
2) Hip fracture Patients & Forecast
3) Osteoporosis Market & Forecast
4) Country Wise Osteoporosis level of Awareness, Guidelines & Policy
5) Country Wise Reimbursement of Medication
6) Company Wise Osteoporosis Drugs Sales & Forecast
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=423187
All the 10 Countries studied in the report are as follows
1) India
2) China
3) Japan
4) Korea
5) Brazil
6) Russia
7) United Kingdom
8) France
9) Germany
10) United States
Worldwide Osteoporosis – Company Wise Drugs Sales Analysis (2010 – 2019)
1) Merck
2) Sanofi
3) Novartis
4) Eli Lilly
5) Amgen
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephonic interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=423187
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
No comments:
Post a Comment